Skip to main content
. Author manuscript; available in PMC: 2007 Apr 5.
Published in final edited form as: Neuropsychopharmacology. 2006 Jan;31(1):77–89. doi: 10.1038/sj.npp.1300791

Table 1.

Analysis of Variance (ANOVA) Summary Tables for Novelty-, Amphetamine-, and Transition from Light to Dark Cycle-Stimulated Locomotion

Condition effect Numerator
DF
Denominator
DF
F p
Novelty
Dose  2  75  0.58 0.56
Time  3 225 137.01 0.00
Dose × Time  6 225  1.31 0.25
Lesion  1  75  15.17 0.00
Dose × Lesion  2  75  0.88 0.42
Time × Lesion  3 225  1.42 0.24
Dose × Time × Lesion  6 225  1.69 0.13
AMPH
Dose  2  75  0.61 0.55
Time  3 225  39.70 0.00
Dose × Time  6 225  1.01 0.42
Lesion  1  75  4.73 0.03
Dose × Lesion  2  75  3.50 0.04
Time × Lesion  3 225  4.83 0.00
Dose × Time × Lesion  6 225  2.23 0.04
Nocturnal
Dose  2  75  0.09 0.91
Time  7 525  30.91 0.00
Dose × Time 14 525  1.47 0.12
Lesion  1  75  13.41 0.00
Dose × Lesion  2  75  1.18 0.31
Time × Lesion  7 525  3.02 0.00
Dose × Time × Lesion 14 525  1.95 0.02